INTELLIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.76 USD | +3.70% |
|
-3.76% | -31.91% |
| 04-15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
| 03-25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 21.53 $ | 21.17 $ | 20.02 $ | 20.76 $ |
| Volume | 849 473 | 859 470 | 1 460 292 | 1 025 682 |
| Change | -1.37% | -1.67% | -5.43% | +3.70% |
| Opening | 21.78 | 21.56 | 20.53 | 20.11 |
| High | 22.85 | 21.73 | 20.66 | 20.99 |
| Low | 21.50 | 21.03 | 19.64 | 19.37 |
Performance
| 1 day | +3.70% | ||
| 1 week | -3.76% | ||
| Current month | -24.54% | ||
| 1 month | -23.17% | ||
| 3 months | -15.88% | ||
| 6 months | -10.36% | ||
| Current year | -31.91% | ||
| 1 year | -42.79% | ||
| 3 years | -76.16% | ||
| 5 years | +21.83% |
Volumes
marketsDaily volume
1 025 682
Estimated daily volume
1 025 682
Avg. Volume 20 sessions
1 193 142
Daily volume ratio
0.86
Avg. Volume 20 sessions USD
24 769 627.92
Record volume 1
23 193 670
Record volume 2
21 818 940
Record volume 3
8 357 691
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
2 002 065 502
Net sales (USD)
36 275 000
Number of employees
526
Sales / Employee (USD)
68 964
Free-Float
98.63 %
Free-Float capitalization (USD)
1 967 904 673
Average Daily Capital Traded
1.24%
Highs and lows
1 week
19.37
22.85
1 month
19.3727.46
Current year
19.3734.87
1 year
19.3747.48
3 years
19.37202.73
5 years
9.18202.73
10 years
9.18202.73
Indicators
Moving average 5 days
21.06
Moving average 20 days
23.69
Moving average 50 days
26.68
Moving average 100 days
27.40
Price spread / (MMA5)
+1.45%
Price spread / (MMA20)
+14.13%
Price spread / (MMA50)
+28.50%
Price spread / (MMA100)
+32.00%
STIM
RSI 9 days
18.04
RSI 14 days
24.45
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.70% | -3.76% | -31.91% | -42.79% | 2B | ||
| +0.38% | +2.98% | +1.51% | +27.89% | 42.75B | ||
| +2.72% | +4.97% | +49.22% | -3.97% | 41.61B | ||
| +1.69% | +6.47% | +8.57% | -16.99% | 41.34B | ||
| -0.45% | +2.14% | -12.36% | +8.21% | 26.59B | ||
| +2.74% | +6.97% | +8.92% | +61.66% | 25.49B | ||
| -0.28% | -0.76% | -25.13% | -26.90% | 18.12B | ||
| +1.58% | +6.43% | +29.17% | +100.43% | 12.24B | ||
| +0.54% | +0.99% | -3.12% | +24.67% | 11.76B | ||
| -0.89% | -1.71% | +6.35% | +2.70% | 11B | ||
| +2.23% | +3.12% | -16.98% | -17.55% | 10.07B | ||
| +1.39% | +4.12% | -6.98% | -8.70% | 9.22B | ||
| +2.53% | +3.12% | +24.77% | -14.18% | 6.65B | ||
| +8.85% | +16.24% | +4.97% | -37.00% | 6.44B | ||
| +1.78% | +2.98% | +25.38% | +56.89% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +1.78% | +3.17% | +4.16% | +7.62% | ||
| Weighted average by Cap. | +1.42% | +3.64% | +8.67% | +10.50% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
5863fd466a3416cdf089c3254a5.WkUjKTJits-e1TnurMgrplNGz0kq6NiAYBes3uLoEmQ.Ix9la14V4bqotF2jmo8G4hEolzESpPXPMSPW5tHacVwpLxBmfiblpsmEDQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 16:00:00 | 20.76 | 126,815 | 696,878 |
| 15:59:59 | 20.75 | 100 | 570,063 |
| 15:59:59 | 20.75 | 100 | 569,963 |
| 15:59:59 | 20.75 | 100 | 569,863 |
| 15:59:58 | 20.75 | 200 | 569,763 |
| 15:59:58 | 20.75 | 100 | 569,563 |
| 15:59:57 | 20.74 | 100 | 569,463 |
| 15:59:56 | 20.75 | 200 | 569,363 |
| 15:59:56 | 20.75 | 138 | 569,163 |
| 15:59:56 | 20.75 | 119 | 569,025 |
Monthly variations
Annual change
| 2024 | -31.91% | ||
| 2023 | -12.61% | ||
| 2022 | -70.49% | ||
| 2021 | +117.35% | ||
| 2020 | +270.82% | ||
| 2019 | +7.47% | ||
| 2018 | -28.98% | ||
| 2017 | +46.61% | ||
| 2016 | -40.68% |
- Stock Market
- Equities
- NTLA Stock
- Quotes Intellia Therapeutics, Inc.
